Citius Pharmaceuticals, Inc. Earnings Per Share (Basic)
Citius Pharmaceuticals, Inc. (CTXR) reported Earnings Per Share (Basic) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.34.
- Citius Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.95.
- Citius Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.38.
- Citius Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.46.
- Citius Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$3.38.
- Citius Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$5.97.
- Citius Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$5.57.
- Citius Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$0.23.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-08-14 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.64 10-Q · filed 2026-08-14 | -$2.12 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$0.95 10-Q · filed 2026-05-15 | -$1.34 10-Q · filed 2026-05-15 | -$1.84 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.56 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-12-31 | -$0.38 10-Q · filed 2026-02-13 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.46 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-09-30 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-12-23 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.26 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.38 10-K · filed 2025-12-23 |
| 2025-06-30 | -$0.80 10-Q · filed 2026-08-14 | -$2.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.27 10-Q · filed 2026-08-14 | -$4.78 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$1.27 10-Q · filed 2026-05-15 | -$2.58 10-Q · filed 2026-05-15 | -$4.14 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$5.70 derived: net income ÷ weighted average shares · filed 2026-05-15 |
| 2024-12-31 | -$1.30 10-Q · filed 2026-02-13 | -$2.89 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$4.45 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$5.81 derived: net income ÷ weighted average shares · filed 2026-02-13 |
| 2024-09-30 | -$1.59 derived: net income ÷ weighted average shares · filed 2025-12-23 | -$3.16 derived: net income ÷ weighted average shares · filed 2025-12-23 | -$4.52 derived: net income ÷ weighted average shares · filed 2025-12-23 | -$5.97 10-K · filed 2025-12-23 |
| 2024-06-30 | -$1.57 10-Q · filed 2025-08-12 | -$2.92 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$4.37 10-Q · filed 2025-08-12 | $0.40 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$1.34 10-Q · filed 2025-05-14 | -$2.79 10-Q · filed 2025-05-14 | $0.21 derived: net income ÷ weighted average shares · filed 2025-05-14 | $0.58 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2023-12-31 | -$1.45 10-Q · filed 2025-02-14 | $0.10 derived: net income ÷ weighted average shares · filed 2025-02-14 | $0.33 derived: net income ÷ weighted average shares · filed 2025-02-14 | |
| 2023-09-30 | $0.03 derived: net income ÷ weighted average shares · filed 2024-12-27 | $0.15 derived: net income ÷ weighted average shares · filed 2024-12-27 | -$5.57 10-K · filed 2024-12-27 | |
| 2023-06-30 | -$0.06 10-Q · filed 2023-08-14 | -$0.15 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | -$0.07 10-Q · filed 2023-05-12 | -$0.10 10-Q · filed 2023-05-12 | ||
| 2022-12-31 | -$0.02 10-Q · filed 2023-02-10 | |||
| 2022-09-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-12-29 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-12-29 | -$0.23 10-K · filed 2022-12-22 | |
| 2022-06-30 | -$0.06 10-Q · filed 2023-08-14 | -$0.18 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.05 10-Q · filed 2023-05-12 | -$0.11 10-Q · filed 2023-05-12 | ||
| 2021-12-31 | -$0.06 10-Q · filed 2023-02-10 | |||
| 2021-09-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-12-22 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-12-22 | -$0.23 10-K · filed 2022-12-22 | |
| 2021-06-30 | -$0.05 10-Q · filed 2022-08-11 | -$0.20 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-12 | -$0.16 10-Q · filed 2022-05-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-19 | |||
| 2013-09-30 | $0.00 10-K · filed 2014-02-06 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | ||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-19 | |||
| 2012-09-30 | $0.00 10-K · filed 2014-02-06 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-09-18 | $0.00 10-Q · filed 2013-09-18 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-13 | $0.00 10-Q · filed 2013-05-13 | ||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-08 | |||
| 2011-09-30 | $0.00 10-K · filed 2013-01-15 | |||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-17 | $0.00 10-Q · filed 2012-08-17 | ||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-11 | $0.00 10-Q · filed 2012-05-11 | ||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |